RESEARCHER PROFILE
Elena V. Babenko
← Back to First Pavlov State Medical University of St. Petersburg
E
First Pavlov State Medical University of St. Petersburg
Elena V. Babenko works in Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment, Transplantation: Methods and Outcomes. Recorded institutional associations include First Pavlov State Medical University of St. Petersburg.
88Publications
583Citations
11H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
2016 · 118 citationsPrognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two‐centre prospective study
2013 · 114 citationsA Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
2020 · 37 citationsNivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients
2019 · 28 citationsRisk‐adapted GVHD prophylaxis with post‐transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations
2018 · 25 citationsA Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
2020 · 24 citationsAn inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort
2014 · 20 citationsNivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
2021 · 20 citationsBenefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia
2018 · 14 citationsDevelopment of donor bone marrow registry in Russian Federation: experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation
2016 · 13 citationsAllogeneic hematopoietic stem cell transplantation in children and adults with acute lymphoblastic leukemia
2016 · 11 citationsClinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A clinical case series of 150 patients
2017 · 11 citationsClinical and immune effects of fecal microbiota transplantation in children with acute graft-versus-host disease
2021 · 10 citationsTrends in Outcome of Hematopoietic Stem Cell Transplantation: 5000 Transplantations and 30 Years of Single-Center Experience
2023 · 9 citationsMeasurement of circulating endothelial cells to support the diagnosis of veno‐occlusive disease after hematopoietic stem cell transplantation
2013 · 8 citationsSingle-agent post-transplantation cyclophosphamide versus calcineurin-based graft-versus-host disease prophylaxis in matched related bone marrow transplantation
2017 · 8 citationsGraft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging Study
2021 · 8 citationsLandscape of alterations in the checkpoint system in myelodysplastic syndrome and implications for prognosis
2022 · 8 citationsEffectiveness of Search for Unrelated Donor of Hematopoietic Stem Cells using Russian System Bone Marrow Donor Search: Experience of RM Gorbacheva Scientific Research Institute of Pediatric Hematology and Transplantation
2017 · 7 citationsTen-year experience of allogeneic haploidentical hematopoietic stem cell transplantation with non-manipulated grafts in children and adolescents with high-risk acute leukemia
2018 · 7 citationsHigh prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide
2019 · 7 citationsBlinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial
2019 · 5 citationsClinical significance of BAALC overexpression for predicting post-transplant relapses in acute myeloid leukemia
2019 · 5 citationsEfficiency of second allogeneic HSCT in the children with acute leukemias with relapses after first transplantation
2019 · 5 citationsProfile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome
2020 · 5 citations